These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17991921)

  • 1. Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions.
    Wagner LI; Wenzel L; Shaw E; Cella D
    J Clin Oncol; 2007 Nov; 25(32):5058-62. PubMed ID: 17991921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions.
    Ganz PA; Gotay CC
    J Clin Oncol; 2007 Nov; 25(32):5063-9. PubMed ID: 17991922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes assessment in cancer trials: taking stock, moving forward.
    Lipscomb J; Reeve BB; Clauser SB; Abrams JS; Bruner DW; Burke LB; Denicoff AM; Ganz PA; Gondek K; Minasian LM; O'Mara AM; Revicki DA; Rock EP; Rowland JH; Sgambati M; Trimble EL
    J Clin Oncol; 2007 Nov; 25(32):5133-40. PubMed ID: 17991933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative.
    Garcia SF; Cella D; Clauser SB; Flynn KE; Lad T; Lai JS; Reeve BB; Smith AW; Stone AA; Weinfurt K
    J Clin Oncol; 2007 Nov; 25(32):5106-12. PubMed ID: 17991929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
    Sloan JA; Berk L; Roscoe J; Fisch MJ; Shaw EG; Wyatt G; Morrow GR; Dueck AC;
    J Clin Oncol; 2007 Nov; 25(32):5070-7. PubMed ID: 17991923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group.
    Brundage M; Osoba D; Bezjak A; Tu D; Palmer M; Pater J;
    J Clin Oncol; 2007 Nov; 25(32):5078-81. PubMed ID: 17991924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels.
    Gondek K; Sagnier PP; Gilchrist K; Woolley JM
    J Clin Oncol; 2007 Nov; 25(32):5087-93. PubMed ID: 17991926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience.
    Bottomley A; Aaronson NK;
    J Clin Oncol; 2007 Nov; 25(32):5082-6. PubMed ID: 17991925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Funding patient-reported outcomes in cancer clinical trials.
    Moinpour CM; Denicoff AM; Bruner DW; Kornblith AB; Land SR; O'Mara A; Trimble E
    J Clin Oncol; 2007 Nov; 25(32):5100-5. PubMed ID: 17991928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life and symptom management research sponsored by the National Cancer Institute.
    Minasian LM; O'Mara AM; Reeve BB; Denicoff AM; Kelaghan J; Rowland JH; Trimble EL;
    J Clin Oncol; 2007 Nov; 25(32):5128-32. PubMed ID: 17991932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making.
    Clauser SB; Ganz PA; Lipscomb J; Reeve BB
    J Clin Oncol; 2007 Nov; 25(32):5049-50. PubMed ID: 17991919
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life measurement in symptom management trials.
    Ganz PA; Goodwin PJ
    J Natl Cancer Inst Monogr; 2007; (37):47-52. PubMed ID: 17951231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluating treatment from the point of view of the patient -PROs (patient-reported outcomes)].
    Bördlein-Wahl I; Hilpert F; Kohlmann T
    Onkologie; 2009; 32 Suppl 1():18-20. PubMed ID: 19521131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of patient-reported outcomes in cancer clinical trials.
    Gotay CC; Kawamoto CT; Bottomley A; Efficace F
    J Clin Oncol; 2008 Mar; 26(8):1355-63. PubMed ID: 18227528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase II designs in cancer clinical trials: current status and future directions.
    Lee JJ; Feng L
    J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
    Willke RJ; Burke LB; Erickson P
    Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to quality of life assessment in oncology: the value of measuring patient-reported outcomes.
    Schwartz CE; Sprangers MA
    Am J Manag Care; 2002 Dec; 8(18 Suppl):S550-9. PubMed ID: 12512979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of patient-reported outcomes in evaluating the quality of oncology care.
    Dennison CR
    Am J Manag Care; 2002 Dec; 8(18 Suppl):S580-6. PubMed ID: 12512982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.